Upgrade to SI Premium - Free Trial

Dyadic International, Inc. (DYAI)

0.52 +0.02 (4.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Q3 Virtual Investor Summit Presentations Now Available On Demand August 31, 2026 6:16 PM - StreetInsider Form SCHEDULE 13G/A DYADIC INTERNATIONAL Filed by: Francisco Trust under agreement dated February 28, 1996 August 17, 2026 9:25 AM - SEC Filing Form 8-K DYADIC INTERNATIONAL For: Aug 13 August 14, 2026 9:18 AM - SEC Filing Form 424B5 DYADIC INTERNATIONAL August 13, 2026 5:25 PM - SEC Filing Dyadic International (DYAI) PT Lowered to $4 at Craig-Hallum August 13, 2026 9:19 AM - StreetInsider Dyadic International raises $2.9M via stock offering and warrants August 13, 2026 8:00 AM - StreetInsider Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement  August 13, 2026 8:00 AM - StreetInsider Form 10-Q DYADIC INTERNATIONAL For: Jun 30 August 12, 2026 8:46 AM - SEC Filing Form 8-K DYADIC INTERNATIONAL For: Aug 12 August 12, 2026 8:46 AM - SEC Filing Dyadic International, Inc. (DYAI) Misses Q2 EPS by 2c August 12, 2026 8:33 AM - StreetInsider Dyadic posts wider Q2 loss as costs rise despite flat revenue August 12, 2026 8:32 AM - StreetInsider Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas August 12, 2026 8:30 AM - Globe NewsWire Dyadic signs new dairy protein deal with European biotech firm August 4, 2026 7:28 AM - StreetInsider Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement August 4, 2026 7:25 AM - StreetInsider Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026 August 3, 2026 4:30 PM - StreetInsider Form 144 DYADIC INTERNATIONAL Filed by: Francisco Trust under agreement dated February 28, 1996 July 29, 2026 3:46 PM - SEC Filing Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days July 28, 2026 8:30 AM - StreetInsider Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days July 28, 2026 8:30 AM - StreetInsider Form 4 DYADIC INTERNATIONAL For: Jul 22 Filed by: Francisco Trust under agreement dated February 28, 1996 July 24, 2026 5:11 PM - SEC Filing Form 8-K DYADIC INTERNATIONAL For: Jul 24 July 24, 2026 8:00 AM - SEC Filing Dyadic regains Nasdaq compliance, stock to remain listed July 24, 2026 7:30 AM - StreetInsider Dyadic Announces Continued Listing on the Nasdaq Capital Market July 24, 2026 7:30 AM - StreetInsider Form 144 DYADIC INTERNATIONAL Filed by: Francisco Trust under agreement dated February 28, 1996 July 21, 2026 5:52 PM - SEC Filing Dyadic launches enzyme program targeting cellulose processing July 16, 2026 8:03 AM - StreetInsider Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program July 16, 2026 8:00 AM - StreetInsider Dyadic receives full $3.1M Gates grant, advances C1 platform work July 7, 2026 7:25 AM - StreetInsider Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential July 7, 2026 7:25 AM - StreetInsider Form SCHEDULE 13G/A DYADIC INTERNATIONAL Filed by: Francisco Trust under agreement dated February 28, 1996 July 6, 2026 6:30 AM - SEC Filing Form 4 DYADIC INTERNATIONAL For: Mar 08 Filed by: Francisco Trust under agreement dated February 28, 1996 July 6, 2026 6:30 AM - SEC Filing Dyadic wins Japan patent for protein expression technology June 29, 2026 7:28 AM - StreetInsider Dyadic Expands IP Protection and Business Development Activities in Japan June 29, 2026 7:25 AM - StreetInsider An Interview with the President & COO: How Dyadic is Commercializing Its Protein Platform Across Multi-Billion-Dollar Markets June 22, 2026 8:49 AM - StreetInsider Form 8-K DYADIC INTERNATIONAL For: Jun 18 June 22, 2026 8:30 AM - SEC Filing Form DEFA14A DYADIC INTERNATIONAL June 18, 2026 9:56 AM - SEC Filing Form 8-K DYADIC INTERNATIONAL For: Jun 18 June 18, 2026 9:56 AM - SEC Filing Form 8-K DYADIC INTERNATIONAL For: Jun 15 June 15, 2026 4:31 PM - SEC Filing Dyadic sees increased interest in C1 platform amid Ebola outbreak response June 15, 2026 7:27 AM - StreetInsider Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption June 15, 2026 7:25 AM - StreetInsider Full Article List